• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR在调节ESKAPE病原体抗生素耐药性中的作用

CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.

作者信息

Saha Ujjayani, Gondi Rashmi, Patil Amrita, Saroj Sunil D

机构信息

Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), Symbiosis Knowledge Village, Lavale, Pune, Maharashtra, 412115, India.

出版信息

Mol Biotechnol. 2023 Jan;65(1):1-16. doi: 10.1007/s12033-022-00543-8. Epub 2022 Aug 8.

DOI:10.1007/s12033-022-00543-8
PMID:35939207
Abstract

The ESKAPE (Enterococcus spp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) isolates both from the clinical settings and food products are demonstrated to gain resistance to multiple antimicrobials. Therefore, the ESKAPE pathogens pose a serious threat to public health, which warrants specific attention to developing alternative novel therapeutics. The clustered regularly interspaced short palindromic repeats associated (CRISPR-Cas) system is one of the novel methods for managing antibiotic-resistant strains. Specific Cas nucleases can be programmed against bacterial genomic sequences to decrease bacterial resistance to antibiotics. Moreover, a few CRISPR-Cas nucleases have the ability to the sequence-specific killing of bacterial strains. However, some pathogens acquire antibiotic resistance due to the presence of the CRISPR-Cas system. In brief, there is a wide range of functional diversity of CRISPR-Cas systems in bacterial pathogens. Hence, to be an effective and safe infection treatment strategy, a comprehensive understanding of the role of CRISPR-Cas systems in modulating antibiotic resistance in ESKAPE pathogens is essential. The present review summarizes all the mechanisms by which CRISPR confers and prevents antibiotic resistance in ESKAPE. The review also emphasizes the relationship between CRISPR-Cas systems, biofilm formation, and antibiotic resistance in ESKAPE.

摘要

临床环境和食品中的ESKAPE(粪肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌属)分离株已被证明对多种抗菌药物产生耐药性。因此,ESKAPE病原体对公众健康构成严重威胁,这值得特别关注开发替代性新型治疗方法。成簇规律间隔短回文重复序列相关(CRISPR-Cas)系统是管理抗生素耐药菌株的新方法之一。特定的Cas核酸酶可针对细菌基因组序列进行编程,以降低细菌对抗生素的耐药性。此外,一些CRISPR-Cas核酸酶具有对细菌菌株进行序列特异性杀伤的能力。然而,一些病原体由于存在CRISPR-Cas系统而获得抗生素耐药性。简而言之,细菌病原体中的CRISPR-Cas系统具有广泛的功能多样性。因此,要成为一种有效且安全的感染治疗策略,全面了解CRISPR-Cas系统在调节ESKAPE病原体抗生素耐药性中的作用至关重要。本综述总结了CRISPR在ESKAPE中赋予和预防抗生素耐药性的所有机制。该综述还强调了ESKAPE中CRISPR-Cas系统、生物膜形成和抗生素耐药性之间的关系。

相似文献

1
CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.CRISPR在调节ESKAPE病原体抗生素耐药性中的作用
Mol Biotechnol. 2023 Jan;65(1):1-16. doi: 10.1007/s12033-022-00543-8. Epub 2022 Aug 8.
2
Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.CRISPR-Cas 系统在 ESKAPE 感染的诊断和治疗中的应用。
Front Cell Infect Microbiol. 2023 Aug 17;13:1223696. doi: 10.3389/fcimb.2023.1223696. eCollection 2023.
3
The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems.CRISPR/Cas 系统作为水生生态系统中一种抗微生物药物耐药性的策略。
Funct Integr Genomics. 2024 May 28;24(3):110. doi: 10.1007/s10142-024-01362-7.
4
CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.CRISPR-Cas:ESKAPE感染治疗与研究的一场革命——临床前研究
Antibiotics (Basel). 2021 Jun 22;10(7):756. doi: 10.3390/antibiotics10070756.
5
Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens.基因组可塑性作为ESKAPE病原体中抗生素耐药性传播的范例。
Environ Sci Pollut Res Int. 2022 Jun;29(27):40507-40519. doi: 10.1007/s11356-022-19840-5. Epub 2022 Mar 29.
6
Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.应对产β-内酰胺酶 ESKAPE 病原体的新兴策略。
Int J Mol Sci. 2020 Nov 12;21(22):8527. doi: 10.3390/ijms21228527.
7
Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.医院感染中克服抗菌药物耐药性的策略:综述与更新。
Infect Disord Drug Targets. 2024;24(6):e260124226226. doi: 10.2174/0118715265276529231214105423.
8
Whole Genome Sequencing of Extended Spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae Isolated from Hospitalized Patients in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省住院患者中产超广谱β-内酰胺酶(ESBL)肺炎克雷伯菌的全基因组测序。
Sci Rep. 2019 Apr 18;9(1):6266. doi: 10.1038/s41598-019-42672-2.
9
Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.肺炎克雷伯菌多个测序菌株中规律成簇间隔短回文重复序列及其相关Cas蛋白(CRISPR/Cas)系统的调查
BMC Res Notes. 2015 Aug 4;8:332. doi: 10.1186/s13104-015-1285-7.
10
Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.食源性 ESKAPE 生物膜与抗菌耐药性:从临床分离株中获得的经验教训。
Pathog Glob Health. 2021 Sep;115(6):339-356. doi: 10.1080/20477724.2021.1916158. Epub 2021 Apr 14.

引用本文的文献

1
Carbapenem Resistance in : Mechanisms, Therapeutics, and Innovations.碳青霉烯类耐药性:机制、治疗与创新
Microorganisms. 2025 Jun 27;13(7):1501. doi: 10.3390/microorganisms13071501.
2
Extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in sub-Saharan Africa: a systematic review and meta-analysis from a One Health perspective.撒哈拉以南非洲地区产超广谱β-内酰胺酶肺炎克雷伯菌:基于“同一健康”视角的系统评价与荟萃分析
BMC Infect Dis. 2025 Jul 1;25(1):843. doi: 10.1186/s12879-025-11276-9.
3
Genomic Insights of Multidrug-Resistant Enterococcus faecalis and Acinetobacter baumannii Isolated from a Sepsis Patient with Pauci-Immune Crescentic Glomerulonephritis, India.
印度一名脓毒性休克少免疫性新月体肾小球肾炎患者分离的耐多药粪肠球菌和鲍曼不动杆菌的基因组分析。
Curr Microbiol. 2024 Nov 27;82(1):16. doi: 10.1007/s00284-024-04003-1.
4
Sub-MIC antibiotics increased the fitness cost of CRISPR-Cas in .亚抑菌浓度的抗生素增加了CRISPR-Cas在……中的适应性代价。
Front Microbiol. 2024 Jul 1;15:1381749. doi: 10.3389/fmicb.2024.1381749. eCollection 2024.
5
Relationship between biofilm formation and antibiotic resistance of and updates on antibiofilm therapeutic strategies.生物膜形成与抗生素耐药性之间的关系以及抗生物膜治疗策略的最新进展。
Front Cell Infect Microbiol. 2024 Feb 23;14:1324895. doi: 10.3389/fcimb.2024.1324895. eCollection 2024.
6
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.基于 CRISPR-Cas 的抗菌剂:设计、挑战和细菌耐药机制。
ACS Infect Dis. 2023 Jul 14;9(7):1283-1302. doi: 10.1021/acsinfecdis.2c00649. Epub 2023 Jun 22.